Application
IHC analysis of mouse hippocampus using Nav1.2 antibody (red) and Parvalbumin antibody (green). C. Confocal merge of panels A and B.Application
IP analysis was performed with rat brain lysates and either Nav1.2 antibody (lane 2) or pre-immune serum (lane 3). Control lysate (lane 1) and the precipitates (Lane 2 and 3) were detected by the same antibody. The lower arrow indicates the IgG heavy chain.Application
WB analysis of rat brain membranes using Nav1.2 antibody at a dilution of 1:200 in the (1) absence or (2) presence of blocking peptide.| Product Name | Nav1.2 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to Nav1.2plays a role in voltage gated sodium ion transport; required for generation of action potentials [RGD, Feb 2006] |
| Immunogen | Peptide (C)ASAESRDFSGAGGIGVFSE, corresponding to amino acid residues 467-485 of rat Nav1.2 (Accession P04775). Intracellular loop between domains I and II . |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHCIPWB |
| ICC/IF:1:200~1:500 IHC:1:50~1:200 IP:1:100~1:500 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Scn2a1 RII/RIIA RNSCPIIR Scn2a2 SCN2A NachII sodium channel voltage-gated type II alpha 1 SCN ScpII |
|---|---|
| Target | Nav1.2 |
Application
IHC analysis of mouse hippocampus using Nav1.2 antibody (red) and Parvalbumin antibody (green). C. Confocal merge of panels A and B.
Application
IP analysis was performed with rat brain lysates and either Nav1.2 antibody (lane 2) or pre-immune serum (lane 3). Control lysate (lane 1) and the precipitates (Lane 2 and 3) were detected by the same antibody. The lower arrow indicates the IgG heavy chain.
Application
WB analysis of rat brain membranes using Nav1.2 antibody at a dilution of 1:200 in the (1) absence or (2) presence of blocking peptide.| Application Notes | ICC/IF:1:200~1:500 IHC:1:50~1:200 IP:1:100~1:500 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Phosphate buffered saline (PBS), pH 7.4, 1% BSA and 0.05% NaN3. |
